Supplementary Tables 1 and 2 from Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21–39 Years

Autor: Philip E. Castle, Walter K. Kinney, Alexander Locke, Hormuzd A. Katki, Li C. Cheung, Thomas Lorey, Nancy E. Poitras, Barbara Fetterman, Mark Schiffman, Julia C. Gage, Michelle I. Silver

Supplemental Table 1: Screening history of diagnosed cancer cases Supplemental Table 2: Outcome by age and baseline histology among women with conservatively managed CIN1/2, CIN2, CIN2/3 biopsy results

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ea65bc8e63bdbc6a996552bbcab012e
https://doi.org/10.1158/1940-6207.22533302

Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting

Autor: Rebecca Landy, Philip E. Castle, Nancy E. Poitras, Hormuzd A. Katki, Thomas Lorey, Walter Kinney, Nicolas Wentzensen, Mark Schiffman, Greg Rydzak, Li C. Cheung, Peter Sasieni

Publikováno v: International Journal of Cancer
Landy, R, Schiffman, M, Sasieni, P D, Cheung, L C, Katki, H A, Rydzak, G, Wentzensen, N, Poitras, N E, Lorey, T, Kinney, W K & Castle, P E 2020, ' Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting ', International Journal of Cancer, vol. 146, no. 3, pp. 617-626 . https://doi.org/10.1002/ijc.32268

US guidelines recommend that most women older than 65 years cease cervical screening after two consecutive negative cotests (concurrent HPV and cytology tests) in the previous 10 years, with one in the last 5 years. However, this recommendation was b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::784fcbb5f0aef5ba59f3180b6737bd24
https://doi.org/10.1002/ijc.32268

Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines

Autor: Maria Demarco, Nicolas Wentzensen, Julia C. Gage, Hormuzd A. Katki, Brian Befano, Nancy E. Poitras, Richard S. Guido, Alexander Locke, Mark Schiffman, Rebecca B. Perkins, Thomas Lorey, Didem Egemen, Li C. Cheung, Amy Wiser, Xiaojian Chen, Philip E. Castle, Walter Kinney

Publikováno v: Journal of Lower Genital Tract Disease

Objective The 2019 American Society for Colposcopy and Cervical Pathology Risk-Based Management Consensus Guidelines for the management of cervical cancer screening abnormalities recommend 1 of 6 clinical actions (treatment, optional treatment or col

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e2565df7a082e9ff3d09ec8024b72f1
https://pubmed.ncbi.nlm.nih.gov/32243308

A study of the risks of CIN3+ detection after multiple rounds of HPV testing: Results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California

Autor: Patti E. Gravitt, Li C. Cheung, Anne Hammer, Brian Befano, Nancy E. Poitras, Mark Schiffman, Philip E. Castle, Nicolas Wentzensen, Walter Kinney, Nicole G. Campos, Maria Demarco, Thomas Lorey

Publikováno v: Hammer, A, Demarco, M, Campos, N, Castle, P, Wentzensen, N, Gravitt, P, Befano, B, Poitras, N, Lorey, T, Kinney, W & Schiffman, M 2020, ' A study of the risks of CIN3+ detection after multiple rounds of HPV testing : Results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California ', International Journal of Cancer, vol. 147, no. 6, pp. 1612-1620 . https://doi.org/10.1002/ijc.32950

Many countries are transitioning to HPV testing for cervical cancer screening, despite a lack of long-term experience. To anticipate multi-round screening performance, we analyzed 15-year HPV testing results at Kaiser Permanente Northern California (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae9d8f86544e053c61cddc0fbaa8d3cf
https://pubmed.ncbi.nlm.nih.gov/32141607

The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen

Autor: Michelle I. Silver, Nicolas Wentzensen, Philip E. Castle, Barbara Fetterman, Mark Schiffman, Nancy E. Poitras, Thomas Lorey, Walter Kinney, Julia C. Gage

Publikováno v: Cancer. 122:3682-3686

BACKGROUND The objective of cervical screening is to detect and treat precancer to prevent cervical cancer mortality and morbidity while minimizing overtreatment of benign human papillomavirus (HPV) infections and related minor abnormalities. HPV/cyt

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::95db4ff9e1fffc2531d0be629a74f86a
https://doi.org/10.1002/cncr.30277